Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.

Khatri BO.

Ther Adv Neurol Disord. 2016 Mar;9(2):130-47. doi: 10.1177/1756285616628766. Epub 2016 Feb 18. Review.

2.

The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk.

Khatri BO, Garland J, Berger J, Kramer J, Sershon L, Olapo T, Sesing J, Dukic M, Rehn E.

Mult Scler Relat Disord. 2015 Jul;4(4):377-9. doi: 10.1016/j.msard.2015.05.003. Epub 2015 May 14.

PMID:
26195059
3.

Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS).

Khatri BO, Pelletier J, Kappos L, Hartung HP, Comi G, Barkhof F, von Rosenstiel P, Meng X, Grinspan A, Hashmonay R, Cohen JA; TRANSFORMS Study Group.

Mult Scler Relat Disord. 2014 May;3(3):355-63. doi: 10.1016/j.msard.2013.11.006. Epub 2013 Dec 12.

PMID:
25876473
4.

The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.

Khatri BO, Foley JF, Fink J, Kramer JF, Cha C, You X, Warth JD, Foulds P.

Int J MS Care. 2014 Spring;16(1):40-7. doi: 10.7224/1537-2073.2013-003.

5.

The effect of plasma exchange on serum anti-JC virus antibodies.

Subramanyam M, Plavina T, Khatri BO, Fox RJ, Goelz SE.

Mult Scler. 2013 Jun;19(7):912-9. doi: 10.1177/1352458512467502. Epub 2012 Dec 11.

PMID:
23232602
6.

Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.

Khatri BO, Kramer J, Dukic M, Palencia M, Verre W.

J Clin Apher. 2012;27(4):183-92. doi: 10.1002/jca.21215. Epub 2012 Apr 9.

PMID:
22488449
7.

Evidence-based guideline update: plasmapheresis in neurologic disorders.

Khatri BO.

Neurology. 2011 Oct 25;77(17):e101; author reply e103-4. doi: 10.1212/WNL.0b013e318230b33f. No abstract available.

PMID:
22025463
8.

Current and emerging multiple sclerosis therapeutics.

Greenberg BM, Khatri BO, Kramer JF.

Continuum (Minneap Minn). 2010 Oct;16(5 Multiple Sclerosis):58-77. doi: 10.1212/01.CON.0000389934.84660.ec.

PMID:
22810598
9.

Therapeutic plasma exchange for worsening multiple sclerosis: does it work?

Khatri BO.

Expert Rev Clin Immunol. 2009 Sep;5(5):491-3. doi: 10.1586/eci.09.42. No abstract available.

PMID:
20477637
10.

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group.

N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20.

11.

Biochemical analysis of CTLA-4 immunoreactive material from human blood.

Tector M, Khatri BO, Kozinski K, Dennert K, Oaks MK.

BMC Immunol. 2009 Sep 22;10:51. doi: 10.1186/1471-2172-10-51.

12.

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.

Khatri BO, Man S, Giovannoni G, Koo AP, Lee JC, Tucky B, Lynn F, Jurgensen S, Woodworth J, Goelz S, Duda PW, Panzara MA, Ransohoff RM, Fox RJ.

Neurology. 2009 Feb 3;72(5):402-9. doi: 10.1212/01.wnl.0000341766.59028.9d.

13.

Should the Babinski sign be part of the routine neurologic examination?

Khatri BO.

Neurology. 2006 May 23;66(10):1607-9; author reply 1607-9. No abstract available.

PMID:
16721958
14.

Mitoxantrone in worsening secondary progressive multiple sclerosis: A prospective, open-label study.

Khatri BO, Wroblewski M, Kramer J, Dukic M, Poplar A, Anderson AJ.

Curr Ther Res Clin Exp. 2006 Jan;67(1):55-65. doi: 10.1016/j.curtheres.2006.02.004.

15.

Vascular access via temporary radial artery catheterization for therapeutic plasma exchange.

Khatri BO.

J Clin Apher. 2003;18(3):134. No abstract available.

PMID:
14569606
16.

Approach to evidence based therapeutic apheresis.

Khatri BO.

J Clin Apher. 2003;18(2):71; author reply 72-4. No abstract available.

PMID:
12874819
17.

Disease modifying therapies in multiple sclerosis.

Khatri BO, McQuillen MP.

Neurology. 2002 Aug 13;59(3):472; author reply 472-3. No abstract available.

PMID:
12184316
18.
19.

Therapeutic apheresis in neurological disorders.

Khatri BO.

Ther Apher. 1999 May;3(2):161-71. Review. No abstract available.

PMID:
10341392
20.

Quantitative MR in the diagnosis of multiple sclerosis.

Haughton VM, Yetkin FZ, Rao SM, Rimm AA, Fischer ME, Papke RA, Breger RK, Khatri BO.

Magn Reson Med. 1992 Jul;26(1):71-8.

PMID:
1625569
Items per page

Supplemental Content

Loading ...
Write to the Help Desk